Quarterly report · Q2
7730.TEDINET S100T9EX
Period2023-09-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.9bn | 2023-09-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.0bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥4.2bn | 2023-09-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥4.6bn | 2023-09-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥4.5bn | 2023-09-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥56.2bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥55.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥50.7bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.6bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥5.1bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥51.6bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥49.8bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥46.2bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥25.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.7bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.8bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.6bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.3bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥32.41 | 2023-09-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.43 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.04 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.84 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.9bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-02-29 | ¥4.2bn |
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2023-02-28 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2023-02-28 | −¥1m |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥917m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | Prior2YearInstant | 22084000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 23798000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 21358000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 22677000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 755000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 998000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 239000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 254000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 40000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 31000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 1002000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 1125000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 169000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 178000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | 3182000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 4154000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | 4688000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12025000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 12025000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | 3182000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 4155000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | 4688000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12026000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Net sales | Prior1YTDDuration | 12025000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | 917000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 1281000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | 1255000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3453000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Operating income | Prior1YTDDuration | 3453000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | 3786000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 4974000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | 5147000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13908000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 13908000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |